372627001: Substance with chelating agent mechanism of action (substance)

SNOMED CT Concept\Substance\Substance categorized by disposition\Chelating agent

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Chelating agent	Is a	kelerende middel/antidot	false	Inferred relationship	Some
Chelating agent	Is a	Allergen class	false	Inferred relationship	Some
Chelating agent	Is a	Drug allergen	false	Inferred relationship	Some
Chelating agent	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that forms a complex with metal ions or other substrates	true	Inferred relationship	Some
Chelating agent	Is a	Substance categorized by disposition	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Apomorphine hydrochloride 2 mg sublingual tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
lægemidler der anvendes ved hyperurikæmi	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing rasburicase (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
rasburicase 1,5 mg pulver og solvens til infusionsvæske, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing potassium iodate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Potassium iodate 85 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
ipecacuanha 7 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
nalmefenhydrochlorid 1 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
nalmefenhydrochlorid 100 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
fomepizol 1 mg/ml injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Tiopronin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
succimer 1 mg hætteglas injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
dexrazoxanhydrochlorid 250 mg hætteglas pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
dexrazoxanhydrochlorid 500 mg hætteglas pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely succimer 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumcellulosephosphat 2,5 g pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naloxonhydrochlorid 400 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naloxonhydrochlorid 1 mg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naloxonhydrochlorid 20 µg/ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
protaminsulfat 250 mg/10 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Sevelamer hydrochloride 800mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Sevelamer hydrochloride 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
calcium 667 mg gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Cysteamine bitartrate 50mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Cysteamine bitartrate 150mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumpolystyrensulfonat 4,1 mækv/g, pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumpolystyrensulfonat 100 % pulver	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumfluorid 1,1 % creme	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Naloxone hydrochloride 2mg/2mL prefilled syringe	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Sevelamer 800mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
digoxinspecifikt antistof 38 mg pulver til injektionsvæske, opløsning, hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
nalmefenhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing succimer (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing tiopronin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing activated charcoal (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing methionine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
dexrazoxanhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
mesna 1 g injektionsvæske, opløsning, hætteglas a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
mesna 200 mg injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
flumazenil 0,1 mg/ml injektionsvæske, opløsning, 10 ml hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
mesna 1 g injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
mesna 400 mg/ampul injektionsvæske, opløsning, hætteglas a 4 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
flumazenil 0,1 mg/ml injektionsvæske, opløsning, 5 ml hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naloxonhydrochlorid + pentazocinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
pralidoximchlorid 1 g/20 ml pulver til injektionsvæske, 20 ml hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
chlorhexidingluconat + natriumnitrit 0,5 %/0,1 % i 70 % IMS, opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Buprenorphine hydrochloride + naloxone hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
buprenorphinhydrochlorid 2 mg + naloxonhydrochlorid 0,5 mg sublingval resoriblet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
buprenorphinhydrochlorid 8 mg + naloxonhydrochlorid 2 mg sublingval resoriblet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naloxonhydrochlorid 2 mg/2 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely sevelamer hydrochloride 800 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
rasburicase 7,5 mg pulver til infusionsvæske, rekonstitution + solvens	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing atropine and pralidoxime (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
atropin/pralidoxim injektionsvæske, opløsning, to autoinjektorer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
atropin + pralidoxim, opløsning, enkelt autoinjektor	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
atropin 2,1 mg + pralidoxim 600 mg, opløsning, enkelt autoinjektor	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
atropin 2 mg + pralidoxim 600 mg opløsning, to autoinjektorer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Naltrexone hydrochloride 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Naltrexone hydrochloride 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumthiosulfat 12,5 g/50 ml injektionsvæske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
apomorphinhydrochlorid 10 mg/ml injektionsvæske, opløsning, cylinderampul a 3 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
digoxinspecifikt antistof 40 mg pulver til injektionsvæske, rekonstitution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Razoxane 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumcellulosephosphat 300 g/flaske pulver til oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
pentetatzinktrinatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
pentetatcalciumtrinatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
pentetatcalciumtrinatrium 200 mg/ml injektionsvæske, opløsning, 5 ml ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
pentetatzinktrinatrium 200 mg/ml injektionsvæske, opløsning, 5 ml ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
phosphatbindende præparat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing lanthanum carbonate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
lanthanumcarbonat 250 mg tyggetablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely lanthanum (as lanthanum carbonate) 500 milligram/1 each conventional release chewable tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing razoxane (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely sevelamer hydrochloride 800 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
flumazenil 0,1 mg/ml injektionsvæske, opløsning, 5 ml hætteglas	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Gadoxetic acid (substance)	Is a	False	Chelating agent	Inferred relationship	Some
Chelation of cornea	Direct substance	False	Chelating agent	Inferred relationship	Some	1
apomorphinhydrochlorid 50 mg injektionsvæske, opløsning, 10 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing dexrazoxane (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Deferasirox (substance)	Is a	True	Chelating agent	Inferred relationship	Some
accidentel forgiftning med kelerende middel	Causative agent	False	Chelating agent	Inferred relationship	Some	1
tilsigtet forgiftning med kelerende middel	Causative agent	False	Chelating agent	Inferred relationship	Some	1
ammoniak + ipecacuanha mikstur	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing ammonia and ipecacuanha (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing polyvalent crotalidae antivenom (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing crotalidae polyvalent immune fab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing precisely lanthanum (as lanthanum carbonate) 750 milligram/1 each conventional release chewable tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
lanthanumcarbonat 1 g tyggetablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing ipecacuanha and sodium bicarbonate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing ammonium bicarbonate and ipecacuanha and sodium bicarbonate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing activated charcoal and magnesium hydroxide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Product containing citric acid and ipecacuanha (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
natriumpolystyrensulfonat 454 g pulver/flaske til suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Naltrexone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Naltrexone-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
naltrexon-mikrosfærer 380 mg pulver til injektionsvæske, opløsning, hætteglas + diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Chelating agent	Inferred relationship	Some
Chelation of cornea	Direct substance	True	Chelating agent	Inferred relationship	Some	1
Unithiol	Is a	True	Chelating agent	Inferred relationship	Some
allergi over for chelerende middel	Causative agent	False	Chelating agent	Inferred relationship	Some	1

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1211155012	Chelating agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3646144010	Substance with chelating agent mechanism of action (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3646150017	Substance with chelating agent mechanism of action	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3723401000005112	kelerende middel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)